Bixiye
QP73-24 Prime Therapeutics/Magellan Rx Management (medical pharmacy solutions program) to become “Prime Therapeutics Management”
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1341 - 1350 ee natiijooyinka 3167
Bixiye
QP71-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024
Bixiye
QP72-24 Provider Survey being Conducted by the Minnesota Department of Human Services (DHS)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024
Bixiye
QP69-24 Provider Press: Q3 2024
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024
Bixiye
QP70-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2024
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024
Bixiye
P54-24 Changes to the Medication Therapy Management (MTM) Program, Effective January 1, 2025
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 03, 2024
Bixiye
P45R1-24 Updated Reimbursement Policies, Effective September 3, 2024
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 03, 2024
Bixiye
P55-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 03, 2024
Bixiye
P57-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 03, 2024
Bixiye
2024 September Bulletins
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 03, 2024